Article
Counseling the at risk patient in the BRCA1 and BRCA2 Era.
Obstetrics and gynecology clinics of North America - 1 Jun 2002
Barnes-Kedar Inbal M, Plon Sharon E
Abstract excerpt
The 5-year experience since the identification of the BRCA1 and BRCA2 genes has shown that genetic evaluation and testing can increase understanding of cancer risks for individuals with a personal or family history of early onset breast cancer and ovarian cancer. However, testing needs to be undertaken in a clinical setting where pretest counseling, including likelihood of identifying a mutation and risks and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
